Hunan Dade Future Technology Industry Group Co., Ltd.

Hunan Dade Future Technology Industry Group Co., Ltd. (formerly Zhangjiajie Dade Brewing Co., Ltd.) was founded in 2007. It is a high-tech enterprise with more than 10 years of history, possessing independent core technologies and independent intellectual property rights. The existing businesses of its subsidiaries have covered the microbiome technology, traditional Chinese medicine research, ecological agriculture, ecological forestry, ecological health and wellness, and other related broad health industries. Relying on multiple invention and process patent technologies, it produces modern pharmaceutical-source vinegar — "Jiuqu Xiangzhi Vinegar" — enriched with highly concentrated polypeptides, flavonoids, ligustrazine, polyphenols, gamma-aminobutyric acid, and other active substances through fermentation and brewing methods.
The Group has established long-term cooperation mechanisms with multiple research institutes and institutions. Based on the consensus formed by domestic experts on the dual-use of pharmaceutical-source vinegar as food and medicine and the homology of fungi and medicine, it combines and integrates high-quality domestic R&D resources and builds an efficient transformation platform for talent, projects, and achievements. Centering on microbiome technology, it conducts collaborative R&D across multiple disciplines, centers, industries, and dimensions, and establishes a diversified talent echelon comprising scientists, professors, doctoral and master's students, ensuring the industrial derivation of the Group's core pharmaceutical-source vinegar project and boosting the implementation of strategic objectives in strategic sectors such as future food, future agriculture, future ecology, future pharmaceutical sources, and future health and wellness.
In the future, the Group will take "composing a new movement for life and health, returning to the origin of life and health" as its corporate vision, adhere to the core philosophy of "independence, combination, integration, and innovation," be guided by human health needs, supported by microbiome technology, and based on artificial intelligence big data as a platform, to build the "Dade Biological Silicon Valley" around pharmaceutical-source vinegar, forming a trillion-level broad health industry cluster.